ROHTO PHARMACEUTICAL CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,036 JPY | +2.50% |
|
+4.03% | +6.79% |
| 04/04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
| 04/04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
| Sales 2024 * | 271B 1.71B 143B | Sales 2025 * | 294B 1.86B 155B | Capitalization | 693B 4.37B 365B |
|---|---|---|---|---|---|
| Net income 2024 * | 31.04B 196M 16.34B | Net income 2025 * | 34.75B 219M 18.3B | EV / Sales 2024 * | 2.28 x |
| Net cash position 2024 * | 74.07B 468M 39B | Net cash position 2025 * | 95.26B 601M 50.15B | EV / Sales 2025 * | 2.03 x |
| P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
19.9
x | Employees | 7,176 |
| Yield 2024 * |
0.88% | Yield 2025 * |
0.96% | Free-Float | 84.57% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.50% | ||
| 1 week | +4.03% | ||
| Current month | +2.33% | ||
| 1 month | -2.57% | ||
| 3 months | -0.59% | ||
| 6 months | -14.60% | ||
| Current year | +6.79% |
1 week
2 886.00
3 070.00
1 month
2 827.003 070.00
Current year
2 827.003 184.00
1 year
2 666.504 117.00
3 years
1 332.004 117.00
5 years
1 238.504 117.00
10 years
670.504 117.00
| Managers | Title | Age | Since |
|---|---|---|---|
Masashi Sugimoto
PSD | President | 62 | 01/19/01 |
Kunio Yamada
CHM | Chairman | 68 | 01/80/01 |
Masamitsu Inoue
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kunio Yamada
CHM | Chairman | 68 | 01/80/01 |
Masanori Kimura
AUD | Comptroller/Controller/Auditor | 66 | 01/82/01 |
| Director/Board Member | 68 | 01/07/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.66% | 15 M€ | +7.34% | ||
| 0.22% | 4 M€ | +13.95% | ||
| 0.14% | 73 M€ | +11.61% | ||
| 0.13% | 10,207 M€ | +14.32% | ||
| 0.13% | 5,115 M€ | +13.58% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 3,036 | +2.50% | 1,219,100 |
| 25/24/25 | 2,962 | +1.37% | 1,467,000 |
| 24/24/24 | 2,922 | -2.04% | 927,100 |
| 23/24/23 | 2,983 | +0.27% | 656,600 |
| 22/24/22 | 2,975 | +1.94% | 919,200 |
Delayed Quote Japan Exchange, April 26, 2024 at 11:30 am IST
More quotes
ROHTO PHARMACEUTICAL CO., LTD. is a Japan-based company principally engaged in the health and beauty care area. The Company primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The Company operates its business in domestic market and overseas markets, including Europe, Asia and America.
Sector
Pharmaceuticals
Calendar
10/05/2024
- Q4 2023 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3,036
JPY
Average target price
3,892
JPY
Spread / Average Target
+28.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.79% | 4.4B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4527 Stock
